How to buy Genetic Technologies shares | A$0.008

Genetic Technologies Limited is a diagnostics & research business based in Australia. Genetic Technologies shares (GTG) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.008 – a decrease of 5.88% over the previous week. Genetic Technologies has a trailing 12-month revenue of around $9,864.

How to buy shares in Genetic Technologies

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Genetic Technologies . Find the share by name or ticker symbol: GTG. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Genetic Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.008, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Genetic Technologies . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Genetic Technologies 's share price?

Since the stock market crash in March caused by coronavirus, Genetic Technologies 's share price has had significant negative movement.

Its last market close was $0.008, which is 15.79% down on its pre-crash value of $0.0095 and 166.67% up on the lowest point reached during the March crash when the shares fell as low as $0.003.

If you had bought $1,000 worth of Genetic Technologies shares at the start of February 2020, those shares would have been worth $400.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $800.00.

Genetic Technologies share price

Use our graph to track the performance of GTG stocks over time.

Genetic Technologies shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$0.008
52-week range	AUDA$0.003 - AUDA$0.014
50-day moving average	AUDA$0.0085
200-day moving average	AUDA$0.0073
Target price	AUDA$0.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.002

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Genetic Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Genetic Technologies Limited by TradingView

Genetic Technologies price performance over time

Historical closes compared with the close of A$0.008 on 2020-10-22

1 week (2020-10-16)	-5.88%
1 month (2020-09-25)	0%
3 months (2020-07-24)	-20.00%
6 months (2020-04-24)	60.00%

1 year (2019-10-24)	45.45%
2 years (2018-10-24)	-22.33%
3 years (2017-10-23)	6.67%
5 years (2015-10-23)	-52.38%

Genetic Technologies financials

Revenue TTM	$9,864
Gross profit TTM	$-241,647
Return on assets TTM	-43.32%
Return on equity TTM	-82.49%
Profit margin	0%
Book value	0.002
Market capitalisation	$66.1 million

TTM: trailing 12 months

Genetic Technologies share dividends

We're not expecting Genetic Technologies to pay a dividend over the next 12 months.

Have Genetic Technologies 's shares ever split?

Genetic Technologies 's shares were split on 28 December 1994.

Genetic Technologies share price volatility

Over the last 12 months, Genetic Technologies 's shares have ranged in value from as little as $0.003 up to $0.014. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Genetic Technologies 's is 1.258. This would suggest that Genetic Technologies 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genetic Technologies overview

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage patient's health in Australia and the United States. It engages in the development of various cancer risk assessment tests under the GeneType name. The company's lead products are GeneType for breast cancer for non-hereditary breast cancer, and GeneType for colorectal cancer. It also offers BREVAGenplus tests. The company sells its products through online health platform. It has research and collaboration agreements with the University of Melbourne, the Translational Genomics Research Institute, Memorial Sloan Kettering, the Ohio State University, and Harvard Nurses' Health Study. Genetic Technologies Limited was incorporated in 1987 and is based in Fitzroy, Australia.

Frequently asked questions

• What percentage of Genetic Technologies is owned by insiders or institutions?

  Currently 14.344% of Genetic Technologies shares are held by insiders and 1.956% by institutions.

• When does the fiscal year end for Genetic Technologies ?

  Genetic Technologies 's fiscal year ends in June.

• Where is Genetic Technologies based?

  Genetic Technologies 's address is: 60-66 Hanover Street, Fitzroy, VIC, Australia, 3065

• What is Genetic Technologies 's ISIN number?

  Genetic Technologies 's international securities identification number is: AU000000GTG7